This brand name is authorized in Poland, United Kingdom
The drug HEMINEVRIN contains one active pharmaceutical ingredient (API):
|
1
Chlormethiazole
UNII 22NJI0W1D2 - CLOMETHIAZOLE EDISYLATE
|
|
Clomethiazole has sedative, muscle relaxant and anticonvulsant properties. It is used for hypnosis in elderly and institutionalised patients, for preanaesthetic sedation and especially in the management of withdrawal from ethanol. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| HEMINEVRIN Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N05CM02 | Clomethiazole | N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CM Other hypnotics and sedatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100028372 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
